Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations

J Infect Dis. 1998 Mar;177(3):823-4. doi: 10.1086/514224.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Cidofovir
  • Cytomegalovirus / drug effects*
  • Cytosine / analogs & derivatives
  • Cytosine / pharmacology
  • Cytosine / therapeutic use
  • Drug Resistance, Microbial
  • Foscarnet / pharmacology
  • Foscarnet / therapeutic use
  • Ganciclovir / pharmacology
  • Ganciclovir / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Organophosphonates*
  • Organophosphorus Compounds / pharmacology
  • Organophosphorus Compounds / therapeutic use

Substances

  • Antiviral Agents
  • Organophosphonates
  • Organophosphorus Compounds
  • Foscarnet
  • Cytosine
  • Cidofovir
  • Ganciclovir